A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants
NCT05112939
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
126
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
RPV LA
DRUG:
CAB LA
Sponsor
Janssen Research & Development, LLC